SLCTR/2024/019
Not yet recruiting
Phase 3
TREATment of Lower Respiratory Tract Infection in Sri LankaA stepped-wedge cluster randomized trial of an electronic clinical decision support tool (eCDST)for the diagnosis and treatment of lower respiratory tract infection (LRTI) in Southern Sri Lanka
Prof. Gayani Tillekeratne0 sitesTBD
Conditionsower Respiratory Tract Infections
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- ower Respiratory Tract Infections
- Sponsor
- Prof. Gayani Tillekeratne
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- •1\.Admitted within prior 48 hours of admission to the hospital
- •2\.Have evidence of new acute respiratory illness (\<14 days of any symptoms), as indicated by at least one of the following:
- •a.New cough or sputum production (New cough will be the initiation of an acute cough or worsening in frequency and intensity of a chronic cough.)
- •b.Chest pain
- •c.Dyspnea or tachypnea (respiratory rate \>20 breaths/minute)
- •d.Abnormal lung examination
- •3\.Have evidence of acute infection, as indicated by at least one of the following:
- •a.Self\-reported fever or chills
- •b.Documented fever ?38 ?C (100\.4 ?F)
Exclusion Criteria
- •An individual who meets any of the following criteria will be excluded from participation in this study:
- •1\.Hospitalized recently (within last 28 days)
- •2\.If they have been enrolled into this clinical trial previously
- •3\.Surgery in the past 7 days
- •4\.If they are unable or unwilling to complete the follow\-up encounter
- •5\.If they will likely be transferred from the medical wards within 24 hours of enrollment (to another ward or to another hospital).
- •6\.If they have underlying conditions or circumstances for which physicians would be unlikely to withhold antibacterials:
- •a.Vasopressor therapy
- •b.Cystic fibrosis
- •c.Known severe immunosuppression
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Common causes and patient outcomes of community-acquired pneumonia in sub-Saharan AfricaISRCTN61173943Infectious Diseases Institute406
Active, not recruiting
Phase 1
Antibiotics for chest infections in children consulting with the GPRespiratory tract infections in children aged between 6 months and 12 yearsMedDRA version: 20.1Level: LLTClassification code 10066740Term: Acute respiratory tract infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 21.1Level: PTClassification code 10024968Term: Lower respiratory tract infectionSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]EUCTR2015-002455-97-GBniversity of Southampton938
Active, not recruiting
Phase 1
ANTIBIOTIC THERAPY IN RESPIRATORY TRACT INFECTIONSCommunity acquired pneumoniaMedDRA version: 20.1Level: LLTClassification code 10010120Term: Community acquired pneumoniaSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]EUCTR2019-001873-10-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS310
Completed
Not Applicable
Subclinical infections of the respiratory tract affecting CVID patientsD83J47Common variable immunodeficiencyBronchiectasisDRKS00009704niversitätsklinikum Freiburg70
Withdrawn
Not Applicable
Protecting against Respiratory tract Infections through human Milk Analysis.pneumoniaRespiratory tract infection1000170810019815NL-OMON48053niversitair Medisch Centrum Utrecht1,000